Palit A, Alexander A M, Slacek B, Taylor C
CSL Limited, 45 Poplar Road, Parkville, Victoria 3052, Australia.
N Z Vet J. 1996 Apr;44(2):64-6. doi: 10.1080/00480169.1996.35936.
An experimental, trivalent, bovine, leptospiral vaccine, containing inactivated Leptospira interrogans serovars pomona and copenhageni and L. borgpetersenii serovar hardjo Hardjobovis, was developed. The experimental vaccine was shown to protect hamsters against virulent challenge with each of the component serovars. In a serological efficacy test in cattle, the experimental vaccine was compared for bioequivalence with a similar product, registered in New Zealand for veterinary use. The experimental vaccine induced higher titres in cattle than the latter mentioned product.
一种实验性的三价牛钩端螺旋体疫苗被研发出来,它含有灭活的问号钩端螺旋体波摩那血清型和哥本哈根血清型以及博氏钩端螺旋体哈德乔哈乔波维斯血清型。实验疫苗显示能保护仓鼠抵御各组成血清型的强毒攻击。在牛的血清学效力试验中,将该实验疫苗与一种在新西兰注册用于兽医用途的类似产品进行生物等效性比较。实验疫苗在牛体内诱导产生的抗体效价比后一种产品更高。